“While the neurons we induced differ from those the body creates itself, we’re excited to show that engineered neurons can acquire highly specific properties. Our findings will allow us to further close the gap between induced and endogenous neurons and thereby render them ever more useful for future translation in regenerative medicine.”
Professor Benedikt Berninger, Professor of Developmental Neurobiology at King’s IoPPN and the study’s senior author
30 October 2024
Brain cells reprogrammed into neurons breaks new ground in regenerative medicine
Researchers have successfully demonstrated how astroglia – cells that support the functioning of the brain – can be reprogrammed into cells resembling interneurons.
The research, published in Science Advances, represents not only an important step forward in neuronal engineering, but also has vital implications for regenerative medicine, which researchers hope could be used to restore dysfunctional brain circuits like those seen in people with epilepsy.
Working with mice shortly after birth, researchers coaxed astroglia to synthesize a protein, Ascl1, that plays a key role in the development of the nervous system. They found that when mutated, Ascl1 became highly efficient in converting astroglia into functioning neurons, much more so than the form of the protein that is generated naturally by the body.
The research team found that the neurons they generated displayed properties that were similar to those native to the brains they were working on, including the ability to fire at very high frequencies, a telltale hallmark of a particular class of interneurons that play a vital role in regulating brain circuitry.
Dr Nicolás Marichal, Research Associate at the Centre for Developmental Neurobiology at King’s IoPPN and one of the study’s lead authors said, “This landmark study’s success in creating neurons from astroglia breaks new ground in regenerative medicine, offering promise for the restoration of aberrant circuitry and brain function in neurological conditions. This work paves the way for further research to exploit these findings and leverage lineage reprogramming of glia into subtype specific neurons as a new therapeutic avenue.”
This research was funded in part by Wellcome Trust, the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme, and the German Research Foundation.
Reprogramming early cortical astroglia into neurons with hallmarks of fast-spiking parvalbumin-positive interneurons by phospho-site deficient Ascl1 (DOI ) (Nicolás Marichal, Sophie Péron, Ana Beltran Arranz, Chiara Galante, Franciele Franco Scarante, Rebecca Wiffen, Carol Schuurmans, Marisa Karow, Sergio Gascón, Benedikt Berninger) was published in Science Advances.
For more information, please contact Patrick O’Brien (Media Manager)
In this story
Professor of Developmental Neurobiology